Innovent Dosed First Participant in Phase 3 Clinical Study of IBI354 (Novel HER2 ADC) for Platinum-resistant Ovarian Cancer
SAN FRANCISCO and SUZHOU, China, March 24, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...
AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates
HONG KONG, March 24, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA shingles vaccine has recently received clinical trial...
Clover Announces U.S. IND Clearance and Initiation of Revaccination Clinical Study for RSV Vaccine Candidate SCB-1019
-- U.S. IND clearance and revaccination trial initiation supports the differentiated global opportunity for Clover's RSV PreF vaccine (SCB-1019) utilizing validated Trimer-Tag platform -- -- Evaluation of SCB-1019 as part of a respiratory...
Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14
EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared for global clinical development. Preclinical highlights： EVM14 induced a...
CROSSFIRE REBRANDS TO JENSEN HUGHES, EXPANDING ITS FIRE SAFETY AND PERFORMANCE-BASED DESIGN ENGINEERING OFFERINGS
AUCKLAND, New Zealand, March 24, 2025 /PRNewswire/ -- Jensen Hughes, a global leader in safety, security and risk-based engineering and consulting, today announced that its partner firm, Crossfire, has officially rebranded to Jensen Hughes. This...
Confidence among small businesses in Singapore rises
Business sentiment among small businesses in Singapore reached a five-year high in 2024, with a positive outlook expected to continue into 2025. Cybersecurity health improved. Sharp decline in businesses planning to innovate in 2025. SINGAPORE,...
Hyundai Capital Australia Obtains Its First Credit Rating of 'A-' from S&P Global Ratings
SEOUL, South Korea, March 24, 2025 /PRNewswire/ -- Hyundai Capital Services ("Hyundai Capital" or the "Company") announced today that its 12th financial subsidiary, Hyundai Capital Australia Pty. Ltd. ("HCAU"), obtained its inaugural credit rating...
Volpara Health Announces BOADICEA Integration and Record ECR 2025 Research Presence
CANBERRA, Australia, March 24, 2025 /PRNewswire/ -- Volpara Health, a global leader in AI-powered breast health solutions and a subsidiary of Lunit, today announced two major milestones: Volpara density is now a validated input to the BOADICEA...